Thursday, January 24, 2008

Signature Genomic Laboratories Gets Private Equity Investment

Spokane, Wash.-based Signature Genomic Laboratories, a provider of molecular diagnostic services, has raised a round of funding from private equity firm Ampersand Ventures. Ampersand Ventures announced the round yesterday, saying that David J. Parker and Herbert H. Hooper of the firm have also been added to Signature Genomic Laboratories' board of directors. Amount of the funding was not disclosed. Signature Genomic Laboratories is also backed by Sacred Heart Medical Center and Pathology Associates Medical Laboratories. Signature Genomic Laboratories provides microarray-based, cytogenetic diagnostics analysis used by clinical geneticists, neurologists, pediatricians, neonatologists, obstetricians, and other researchers.